[go: up one dir, main page]

DK0400522T3 - Fremgangsmåde til fremstilling af mikroniserede bionedbrydelige partikler - Google Patents

Fremgangsmåde til fremstilling af mikroniserede bionedbrydelige partikler

Info

Publication number
DK0400522T3
DK0400522T3 DK90110055.2T DK90110055T DK0400522T3 DK 0400522 T3 DK0400522 T3 DK 0400522T3 DK 90110055 T DK90110055 T DK 90110055T DK 0400522 T3 DK0400522 T3 DK 0400522T3
Authority
DK
Denmark
Prior art keywords
preparation
biodegradable particles
micronized
micronized biodegradable
particles
Prior art date
Application number
DK90110055.2T
Other languages
English (en)
Inventor
Gojko Dr Muacevic
Bernd Dr-Dipl-Chem Zierenberg
Original Assignee
Boehringer Ingelheim Int
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int, Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Int
Application granted granted Critical
Publication of DK0400522T3 publication Critical patent/DK0400522T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/773—Nanoparticle, i.e. structure having three dimensions of 100 nm or less
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906—Drug delivery
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/915—Therapeutic or pharmaceutical composition

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polyesters Or Polycarbonates (AREA)
DK90110055.2T 1989-05-31 1990-05-28 Fremgangsmåde til fremstilling af mikroniserede bionedbrydelige partikler DK0400522T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3917617A DE3917617A1 (de) 1989-05-31 1989-05-31 Mikronisierte bioabbaubare partikel, verfahren zur ihrer herstellung und ihre verwendung

Publications (1)

Publication Number Publication Date
DK0400522T3 true DK0400522T3 (da) 1995-04-03

Family

ID=6381699

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90110055.2T DK0400522T3 (da) 1989-05-31 1990-05-28 Fremgangsmåde til fremstilling af mikroniserede bionedbrydelige partikler

Country Status (9)

Country Link
US (1) US5871771A (da)
EP (1) EP0400522B1 (da)
JP (1) JP3002499B2 (da)
AT (1) ATE116541T1 (da)
CA (1) CA2017851C (da)
DE (2) DE3917617A1 (da)
DK (1) DK0400522T3 (da)
ES (1) ES2066038T3 (da)
GR (1) GR3015634T3 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4041563A1 (de) * 1990-12-22 1992-06-25 Sanol Arznei Schwarz Gmbh Verfahren zur herstellung wirkstoffhaltiger mikropartikel aus hydrolytisch abbaubaren polymeren
JPH06212726A (ja) * 1993-01-13 1994-08-02 Natl House Ind Co Ltd 家屋の妻面構造
US5780213A (en) * 1993-12-22 1998-07-14 Fuji Photo Film Co., Ltd. Photographic printing paper support
CZ92497A3 (en) * 1994-09-29 1997-08-13 Andaris Ltd Micro-particles of water soluble material intended for use in therapy or diagnosis, inhaling apparatus containing such particles and application of a therapeutical agent
US6126919A (en) 1997-02-07 2000-10-03 3M Innovative Properties Company Biocompatible compounds for pharmaceutical drug delivery systems
TW577758B (en) 1997-10-27 2004-03-01 Ssp Co Ltd Intra-articular preparation for the treatment of arthropathy
AU2001243635A1 (en) * 2000-03-14 2001-09-24 Brown University Research Foundation Methods and compositions for regulating memory consolidation
CA2413692C (en) * 2000-06-27 2011-10-18 Vectura Limited Method of making particles for use in a pharmaceutical composition
EP2266549B1 (en) 2000-06-27 2019-08-07 Vectura Limited Method of making particles for use in a pharmaceutical composition
US6723190B1 (en) * 2000-10-27 2004-04-20 The United States Of America As Represented By The Secretary Of The Navy ESD sensitivity in titanium/boron compositions
DE10061932A1 (de) * 2000-12-13 2002-10-24 Pharmatech Gmbh Wirkstoffhaltige Mikropartikel und Verfahren zur Herstellung der Mikropartikel durch Abrasion
EP1408876A4 (en) 2001-06-22 2004-09-22 Durect Corp ZERO ORDER COAXIAL IMPLANTS WITH EXTENDED RELEASE
JP4679822B2 (ja) * 2002-03-13 2011-05-11 ノバルティス アーゲー 医薬微粒子
DE10218107A1 (de) * 2002-04-23 2003-11-20 Jenapharm Gmbh Verfahren zum Herstellen von Kristallen von Steroiden, danach erhältliche Kristalle und deren Verwendung in pharmazeutischen Formulierungen
CN1902254A (zh) * 2003-12-30 2007-01-24 3M创新有限公司 医药组合物及其制备方法
JP2005206491A (ja) * 2004-01-21 2005-08-04 Medgel Corp 肺気腫を治療するための経肺投与用製剤
US20070106271A1 (en) * 2005-11-09 2007-05-10 Searete Llc, A Limited Liability Corporation Remote control of substance delivery system
US8968787B2 (en) 2010-05-24 2015-03-03 Micro Powders, Inc. Composition comprising biodegradable polymers for use in a cosmetic composition
CN113384540B (zh) * 2021-07-22 2022-04-01 北京海泰天正医药科技有限公司 盐酸丙卡特罗颗粒组合物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3264782D1 (en) * 1981-10-16 1985-08-22 Sanol Arznei Schwarz Gmbh Medicinal formulation
US4818542A (en) * 1983-11-14 1989-04-04 The University Of Kentucky Research Foundation Porous microspheres for drug delivery and methods for making same
GB8613811D0 (en) * 1986-06-06 1986-07-09 Phares Pharm Res Nv Composition & method
CH665558A5 (en) * 1985-10-09 1988-05-31 Debiopharm Sa Phase sepn. prodn. of microcapsules for water soluble pharmaceuticals - using fluoro-substd. aliphatic hydrocarbon as non-solvent in the hardening stage
SE8601457D0 (sv) * 1986-04-01 1986-04-01 Draco Ab Compositions of liposomes and b?712-receptor active substances for inhalation
DE3784594T2 (de) * 1986-08-11 1994-01-05 Innovata Biomed Ltd Mikrokapseln enthaltende pharmazeutische Zusammensetzungen.
JPS63122620A (ja) * 1986-11-12 1988-05-26 Sanraku Inc ポリ乳酸マイクロスフエア及びその製造方法

Also Published As

Publication number Publication date
JP3002499B2 (ja) 2000-01-24
EP0400522A2 (de) 1990-12-05
EP0400522B1 (de) 1995-01-04
GR3015634T3 (en) 1995-06-30
CA2017851A1 (en) 1990-11-30
EP0400522A3 (de) 1992-10-14
JPH0317014A (ja) 1991-01-25
DE3917617A1 (de) 1990-12-06
ATE116541T1 (de) 1995-01-15
US5871771A (en) 1999-02-16
ES2066038T3 (es) 1995-03-01
CA2017851C (en) 2001-11-20
DE59008170D1 (de) 1995-02-16

Similar Documents

Publication Publication Date Title
DK0400522T3 (da) Fremgangsmåde til fremstilling af mikroniserede bionedbrydelige partikler
FI884636A0 (fi) Pitkävaikutteisen farmaseuttisen valmisteen valmistusmenetelmä
FI904801A7 (fi) Seos
NO904453L (no) Fremgangsmaate for fremstilling av bituminoese materialer.
FI903752A7 (fi) Menetelmä 1,2,3,4-tetrahydro-9-akridiiniamiinin johdannaisten valmistamiseksi
DK0579996T3 (da) 5,10-Methylentetrahydrofolsyrecyclodextrin-inklusionsforbindelser
DK0417680T3 (da) Fremgangsmåde til fremstilling af 1,1,1,2-tetrafluorethan
FI895662A0 (fi) Menetelmä 3,4-difluorisubstituoidun benseenin valmistamiseksi
EP0340391A3 (en) 1,4-disubstituted-2,3,4,6-tetrahydroxy-1,4-diphosphorinane and their oxides or sulfides
DK0499157T3 (da) Fremgangsmåde til fremstilling af 1,3-dioxoler
NO901321L (no) Fremgangsmaate for fremstilling av polycykliske aminer.
BR8905745A (pt) Composicao de fragrancia,processo para a preparacao de compostos e uso dos ditos compostos
NO903338L (no) Fremgangsmaate for mikrobiologisk fremstilling av l-carnitin.
KR950703559A (ko) 신규한 축합 티아졸 유도체, 이의 제조방법 및 이를 함유하는 약제학적 조성물(Novel condensed thiazole derivative, process for producing the same, and pharmaceutical composition containing the same)
PT84750B (pt) Processo de preparacao de uma composicao para o envenenamento de roedores, a base de derivados de 1,4-naftoquinona
FI910159A7 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten 9a-hydroksi-3-okso- 4,24(25)-stigmastadieeni-26-happojohdannaisten valmistamiseksi
PT86665A (pt) Process for the preparation of 14,15-substituted lanosterols and of hypocholesterolemic compositions containing the same
DK0377437T3 (da) Fremgangsmåde til fremstilling af 2,4-diamino-6-piperidinylpyrimidin-3-N-oxid
FI910816L (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 3H-6H-1,4,5a,8a,-tetra-atsa-asenaftyleeni-3,5(4H)-dionijohdannaisten valmistamiseksi
FI902983A7 (fi) Seos
FI930237A7 (fi) Menetelmä 4,6-dialkoksipyrimidiinien valmistamiseksi
BR8706321A (pt) Composicao pesticida,composicao de resina pesticida e processo para a preparacao de uma composicao pesticida
NO894037D0 (no) Fremgangsmaate for fremstilling av nye 2-metoksykarbonyl-substituerte n,n'-di(trimetoksybenzoyl) piperaziner.
DE3888697D1 (de) 2,3-thiomorpholinedion-2-oxim-derivate, arzneimittelzusammensetzungen und verfahren zur herstellung.
ATE39925T1 (de) L-arginin-isoxicamat.